Heron Therapeutics's total assets for Q1 2026 were $246.22M, a decrease of -3.78% from the previous quarter. HRTX total liabilities were $237.08M for the fiscal quarter, a -1.85% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.